Is Johnson & Johnson's (NYSE:JNJ) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Most readers would already be aware that Johnson & Johnson's (NYSE:JNJ) stock increased significantly by 11% over ...
Final Trade: TEVA, JNJ, TJX, BABA
The final trades of the day with the Fast Money traders.
Is Johnson & Johnson (JNJ) the Best Non-Tech Stock to Buy Now for Long Term?
We recently compiled a list of the 10 Best Non-Tech Stocks to Buy Now for Long Term. In this article, we are going to take a ...
JNJ met main goal in late-stage trial for ulcerative colitis treatment
Johnson & Johnson (JNJ) said on Friday that its late-stage study of TREMFYA as an induction therapy for adults with ...
Johnson & Johnson (NYSE:JNJ) Goes to Court for Third Time over $10B Talc Bankruptcy Plan
Johnson & Johnson (JNJ) begins on Tuesday its third attempt to push through a multi-billion-dollar settlement relating to ...
AbbVie Vs. Johnson & Johnson: Graham Would Prefer The Consumer Healthcare Giant
Johnson & Johnson may outshine AbbVie as a top defensive stock pick. Read how Ben Graham's framework evaluates each ...
Johnson & Johnson: Rich History Of Excellence Poised To Endure
Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...
Johnson & Johnson Sees Unusually High Options Volume (NYSE:JNJ)
Johnson & Johnson (NYSE:JNJ – Get Free Report) was the target of some unusual options trading on Thursday. Stock traders purchased 58,414 call options on the stock. This is an increase of ...
Johnson & Johnson (JNJ): Among the Best Forever Stocks to Buy Right Now
The first month of 2025 was an interesting one, with inflation rising faster than expected, giving another motivation for the ...
KLCM Advisors Inc. Raises Stock Holdings in Johnson & Johnson (NYSE:JNJ)
KLCM Advisors Inc. grew its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 2.0% in the fourth quarter, ...
Johnson & Johnson (JNJ) Receives a Buy from RBC Capital
In a report released yesterday, Shagun Singh Chadha from RBC Capital initiated coverage with a Buy rating on Johnson & Johnson (JNJ – ...
Protagonist Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
NEWARK, CA / ACCESS Newswire / February 21, 2025 / Protagonist Therapeutics (NASDAQ:PTGX) ("Protagonist" or "the Company") today reported financial results for the fourth quarter and full year ended ...